{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:57:36Z","timestamp":1791925056505,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T00:00:00Z","timestamp":1431129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10067-015-2953-7","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T05:25:35Z","timestamp":1431062735000},"page":"2119-2126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients"],"prefix":"10.1007","volume":"34","author":[{"given":"Cl\u00e9ment","family":"Morin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Fardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,9]]},"reference":[{"key":"2953_CR1","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","volume":"50","author":"L Fardet","year":"2011","unstructured":"Fardet L, Petersen I, Nazareth I (2011) Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20\u00a0years. Rheumatology (Oxford) 50:1982\u20131990","journal-title":"Rheumatology (Oxford)"},{"key":"2953_CR2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","volume":"157","author":"L Fardet","year":"2007","unstructured":"Fardet L, Flahault A, Kettaneh A, Tiev KP, G\u00e9n\u00e9reau T, Tol\u00e9dano C, Lebb\u00e9 C, Cabane J (2007) Corticosteroid-induced clinical adverse events: frequency, risk factors and patient\u2019s opinion. Br J Dermatol 157:142\u2013148","journal-title":"Br J Dermatol"},{"key":"2953_CR3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.revmed.2012.02.001","volume":"33","author":"L Zerah","year":"2012","unstructured":"Zerah L, Arena C, Morin AS, Blanchon T, Cabane J, Fardet L (2012) Patients\u2019 beliefs about long-term glucocorticoid therapy and their association to treatment adherence. Rev Med Interne 33:300\u2013304","journal-title":"Rev Med Interne"},{"key":"2953_CR4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1365-2133.2010.09877.x","volume":"163","author":"C Arena","year":"2010","unstructured":"Arena C, Morin AS, Blanchon T, Hanslik T, Cabane J, Dupuy A, Fardet L (2010) Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy. Br J Dermatol 163:832\u2013837","journal-title":"Br J Dermatol"},{"key":"2953_CR5","unstructured":"Owens P, Elixhauser A (2007) Adverse drug events in U.S. Hospitals, 2004. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. http:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb29.pdf"},{"key":"2953_CR6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.clinthera.2011.09.009","volume":"33","author":"E Sarnes","year":"2011","unstructured":"Sarnes E, Crofford L, Watson M, Dennis G, Kan H, Bass D (2011) Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review. Clin Ther 33:1413\u20131432","journal-title":"Clin Ther"},{"key":"2953_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.respe.2008.12.009","volume":"57","author":"A Perdoncini-Roux","year":"2009","unstructured":"Perdoncini-Roux A, Blanchon T, Hanslik T, Lasserre A, Turbelin C, Dorleans Y, Cabane J, Fardet L (2009) General practitioners\u2019 perception of the impact of corticosteroid-induced adverse events. Rev Epidemiol Sante Publique 57:93\u201397","journal-title":"Rev Epidemiol Sante Publique"},{"key":"2953_CR8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/ard.2009.114579","volume":"69","author":"MC Goes Van der","year":"2010","unstructured":"Van der Goes MC, Jacobs JWG, Boers M, Andrews T et al (2010) Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 69:1015\u20131021","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2953_CR9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jbspin.2013.07.001","volume":"81","author":"K Nassar","year":"2014","unstructured":"Nassar K, Janani S, Roux C, Rachidi W, Etaouil N, Mkinsi O (2014) Long-term systemic glucocorticoid therapy: patients\u2019 representations, prescribers\u2019 perceptions, and treatment adherence. Joint Bone Spine 81(1):64\u201368","journal-title":"Joint Bone Spine"},{"key":"2953_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.revmed.2013.02.015","volume":"34","author":"J Poisson","year":"2013","unstructured":"Poisson J, Six M, Morin C, Fardet L (2013) Glucocorticoid therapy: what is the information sought by patients? Traffic analysis of the website cortisone-info.fr. Rev Med Interne 34:255\u2013257","journal-title":"Rev Med Interne"},{"key":"2953_CR11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.21984","volume":"55","author":"JR Curtis","year":"2006","unstructured":"Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG (2006) Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 55:420\u2013426","journal-title":"Arthritis Rheum"},{"key":"2953_CR12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2007.04.018","volume":"57","author":"L Fardet","year":"2007","unstructured":"Fardet L, Cabane J, Lebb\u00e9 C, Morel P, Flahault A (2007) Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study. J Am Acad Dermatol 57:604\u2013609","journal-title":"J Am Acad Dermatol"},{"key":"2953_CR13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ajp.2011.11071009","volume":"169","author":"L Fardet","year":"2012","unstructured":"Fardet L, Petersen I, Nazareth I (2012) Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry 169:491\u2013497","journal-title":"Am J Psychiatry"},{"key":"2953_CR14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","volume":"68","author":"D Huscher","year":"2009","unstructured":"Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, Zink A, Buttgereit F (2009) Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68:1119\u20131124","journal-title":"Ann Rheum Dis"},{"key":"2953_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","volume":"44","author":"D Czock","year":"2005","unstructured":"Czock D, Keller F, Rasche FM, H\u00e4ussler U (2005) Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44:61\u201398","journal-title":"Clin Pharmacokinet"},{"key":"2953_CR16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.lpm.2012.01.007","volume":"41","author":"C Jeunne Le","year":"2012","unstructured":"Le Jeunne C (2012) Pharmacology of glucocorticoids. Presse Med 41:370\u2013377","journal-title":"Presse Med"},{"key":"2953_CR17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/acr.21796","volume":"65","author":"RA Overman","year":"2013","unstructured":"Overman RA, Yeh JY, Deal CL (2013) Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res 65:294\u2013298","journal-title":"Arthritis Care Res"},{"key":"2953_CR18","first-page":"1","volume":"2","author":"M Iudici","year":"2014","unstructured":"Iudici M, Russo B, Mitidieri M, Cuomo G, Valentini G (2014) Glucocorticoids in systemic sclerosis: patients\u2019 beliefs and treatment adherence. Scand J Rheumatol 2:1\u20139","journal-title":"Scand J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2953-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-2953-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2953-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:41Z","timestamp":1559120261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-2953-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,9]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2953"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-2953-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,9]]}}}